The evaluation of the safety, efficacy, and long-term stability of LASIK procedures utilizing novel platform comprising a femtosecond and excimer laser and multiple networked diagnostics. Setting: Private clinical ophthalmology practice.
Introduction
Laser-assisted in situ keratomileusis (LASIK) is a widely accepted method for correcting the refractive error, 1, 2 as evidenced by the long number of publications in the peer-reviewed literature.
In recent years, the use of bladeless LASIK surgery utilizing a femtosecond laser (named for its ultrashort pulses, with duration of few femtoseconds or quadrillionths of a second) for lamellar flap creation, as an alternative option to the mechanical microkeratome, 3, 4 has been studied as well. A second laser involved in the procedure, the excimer provides the ablation and has also evolved significantly over the course of the past 10 years. Contemporary generation excimer lasers for refractive surgery operate with high pulse repetition (more than 400 Hz) 5, 6 and scanning spot 7 and can provide customized ablation, including aspheric ablation profiles, 8 wavefront-guided, 9, 10 or topography-guided 11, 12 treatments.
These improvements have further advanced the clinical outcomes of the LASIK procedure 1, 13 in correcting not just the spherocylindrical refractive error, but also the higher-order aberrations, by reducing the induced spherical aberration following myopic ablation. 5, 14, 15 The purpose of this study was to evaluate the safety, efficacy, and long-term stability of myopic and myopic astigmatism corrective LASIK procedures utilizing the WaveLight ® FS200 femtosecond 16 and EX500 excimer laser refractive surgery platform.
Materials and methods
This prospective interventional case series study received approval by the Ethics Committee of our Institution, adherent to the tenets of the Declaration of Helsinki. Informed consent was obtained from each subject at the time of the intervention. The study was conducted on patients in our clinical practice, during scheduled pre-and postoperative procedure visits.
The 109 consecutive patients enrolled in the study underwent uncomplicated primary bilateral LASIK performed by the same surgeon (AJK) using the same refractive surgery platform (WaveLight FS200 Femtosecond Laser and WaveLight EX500 Excimer Laser; Alcon Laboratories, Ft Worth, TX, USA), between September 2009 and September 2010.
Preoperative spherical equivalent (SE) was between 0.00 and −8.00 diopters (D), and up to 4.25 D of cylinder refractive error.
Exclusion criteria for the LASIK operation were: systemic or ocular diseases, eyes with history of corneal dystrophy or herpetic eye disease, topographic evidence of keratoconus (as evidenced by Placido topography) or warpage from contact lenses, corneal scaring, glaucoma, severe dry eye, and collagen vascular diseases. The average flap thickness (planned 110 µm) was 107 ± 5 µm. The average flap diameter (planned 8.00 mm) was 7.95 ± 0.05 mm. Flap thickness was measured by subtracting the central cornea pachymetry, measured with the EX500 following flap creation, from the central cornea pachymetry, measured preoperatively with the WaveLight Oculyzer ™ II diagnostic device (Alcon Laboratories) (with integrated Scheimpflug topography camera) and the WaveLight OB820 biometer (Alcon Laboratories) that were both integrated within the platform. 17 All eyes were evaluated preoperatively for best corrected distance visual acuity (CDVA) and postoperatively for uncorrected distance visual acuity (UDVA). Preoperative evaluations included wavefront analysis, pupillometry, and contrast sensitivity. Postoperative examination included manifest and dilated refraction, slit-lamp microscopy, tonometry, and keratometry, by means of corneal topography and tomography assessment.
Postoperative follow-up examinations were conducted at 1 week, 3 months, 6 months, and 1 year. Data processed in this study represent the 3-, 6-, and 12-month visits.
Data were loaded and processed using web-based refractive analysis software (IBRA Ophthalmic Outcome Analysis System; Zubisoft GmbH, Oberhasli, Switzerland).
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Results
Of the 190 eyes, 96 (50.5%) were right eyes, while 94 (49.5%) were left eyes; 86 (45.3%) belonged to female patients, while 104 (54.7%) belonged to male patients. Mean age at the time of the operation was 28.8 ± 7.8 years, range 17 to 52.
As shown in Table 1 , the preoperative UDVA was 0.04 ± 0.17 (decimal), range 0.001 to 0. 
UDVA outcome and stability
The UDVA (monocular) outcome and stability at 3, 6, and 12 months (Figure 1) shows that 94.7% of the eyes had postoperative unaided visual acuity better than 1.0 (decimal) at month 3, and maintained this for 1 year. Figure 1 also depicts the preoperative best CDVA.
Safety of CDVA
As shown in Figure 2 , the safety distance visual acuity graph, at the 3-month visit comparison of preoperative best CDVA and postoperative UDVA, indicates that 33.3% of the eyes submit your manuscript | www.dovepress.com
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Kanellopoulos and Asimellis were unchanged, while 59.2% of the eyes gained one Snellen line and 6.4% gained two or more Snellen lines. The proportion of eyes losing one line was less than 2%, and so was the proportion of eyes losing two Snellen lines.
Refractive stability and predictability
The refractive stability is demonstrated by the SE correction, at the 12-month postoperative visit ( Figure 3 ). Defocus equivalent results are presented in Figure 4 .
Predictability is demonstrated in Figure 5 , where the achieved SE versus attempted SE (in D) was plotted, for gate = 0. In a similar fashion, the SE refraction is depicted in Figure 6 , where SE during the 3-month, 6-month, and 12-month postoperatively follow-up visits are shown.
Gain/loss in Snellen lines
Keratometric and astigmatic changes and stability
The comparison between postoperative and preoperative refractive astigmatism is demonstrated by the percentage of eyes within 0.25 D of postoperative refractive astigmatism.
As shown in Figure 7 , at the 3-month visit, 94.7% of the eyes showed astigmatism less than 0.25 D, at the 6-month visit, and 97.9% showed less than 0.5 D refractive astigmatism at the 12-month visit.
Of interest is the comparison between postoperative and preoperative refractive astigmatism, in the form of a double angle-cylinder scatterplot of the surgically induced astigmatism minus the target-induced astigmatism, an example of which is shown in Figure 8 .
The keratometric changes and stability is demonstrated by the K-flat and K-steep average values during the 1-, 3-, 6-, and 12-month postoperative visits ( Figure 9 ). 
Discussion
In clinical practice, we used the combined WaveLight refractive surgery laser platform comprising the FS200 Femtosecond Laser, 16 the EX500 Excimer Laser, and the series of networked diagnostic devices (including Vario Placido topography, Oculyzer II Scheimpflug topography imaging, a Tscherning wavefront system, and the OB820 biometer), that together constitute the Refractive Suite ® . 17 Clinical results and features of the previous generations of the WaveLight excimer series (200 Hz Allegretto and 400 Hz Eye Q) have been reported by our team. 12, 19 The EX500 laser, the latest evolution of the aforementioned excimer lasers, employs a 1050 Hz multidimensional active tracker (with estimated response time [latency] of 2 milliseconds and ability to track pupil size from 1.5 to 8 mm), online optical pachymetry (enabling central cornea pachymetric measurements immediately following flap removal and during the LASIK procedure) to dynamically assess tissue removal, an onboard nitrogen generator (making the unit self-sufficient for nitrogen), and a 500 Hz laser pulse frequency that enables the treatment of each D of myopia in 1.4 seconds (based on a 6.0 mm optical zone of treatment). This enhanced speed may reduce stromal dehydration, flap shrinkage, sensitivity to eye movements, and patient fixation fatigue. 20 The flying spot in the excimer allows only one pulse in five to overlap and optimizes temporal and spatial shot distribution. Additional pulses are sent to the periphery to compensate for energy loss, reducing the potential for nighttime glare.
The Refractive Suite operates on its own Ethernet network and allows the import of diagnostic data from networked screening devices into the planning software tools of both lasers. For example, the Suite offers the ability to import the topometry data from the Oculyzer II into the laser treatment planning mode and to accordingly customize the excimer treatment to the cornea (for eg, topography-guided treatment). 12 The long-term clinical results with the systems described above reported here show impressive refractive outcome, The predictability of the outcome was extremely accurate. As shown in Figure 5 , of the 190 eyes shown, one eye (0.5%) was marked with red, indicating overcorrection, 180 (95%) were marked with green, within 0.5 D, and nine (5%) were marked with blue, indicating undercorrection.
The stability of the outcome is evidenced by the stability of the SE over the course of 12 months, as shown in These results compare very favorably to other studies, 21 in which for the same range of ±1.0 D, the proportions were in the range of 98%.
More importantly, 0% cases had hyperopic regression up to +0.5 D, at the 1-year follow-up visit.
The slight positive slope in the keratometric readings (similar for both the flat and the steep meridian) might be an indication of mild progressive corneal steepening. In Figure 9 we observe a +0.1 D of keratometric power increase over the course of 1 year. This is an indication that corneal stiffening might be required for all LASIK cases, in the form of cross linking applied at the corneal stroma prior to repositioning of the flap. 22 This procedure, known as LASIK-extra, is under investigation by our team. 23 The vector analysis of cylinder showed overall satisfactory results with a relatively good index of success. The analysis of surgically induced astigmatism and target-induced astigmatism disclosed the presence of some systematic induced cylinder (Figure 7) , with a constant trend toward the 90° axis. This may be related to the position of the hinge (always nasal) or it may be due to the hinge protection software. Regarding the cylinder correction (Figure 7 ), in 98% of the eyes, after 1 year, the residual cylinder power was less than 0.5 D, compared with 67.4% of the eyes that preoperatively had cylinder power more than 0.25 D and up to 6.00 D.
Conclusion
The long-term clinical results with the Alcon/WaveLight Refractive Suite show impressive refractive outcome, predictability, and stability. Safety, efficacy, and long term stability are also remarkable. The networking of diagnostic devices increases ease and safety when both the femtosecond and the excimer lasers are used.
